Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ARTL
ARTL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ARTL ETF News Today | Earnings, Events & Price Alerts
ARTL News
Artelo Biosciences Reports Positive Clinical Data and Strategic Developments
Feb 24 2026
Yahoo Finance
Keysight Technologies Quarterly Earnings Beat Estimates
Feb 24 2026
Benzinga
Maxim Group Lowers Artelo Biosciences Rating to Hold
Nov 19 2025
Benzinga
Wolfspeed Shares Surge Over 50%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 30 2025
Benzinga
Artelo Biosciences Initiates Underwritten Public Offering to Secure Funding
Sep 30 2025
SeekingAlpha
Artelo Biosciences Unveils Plans for Underwritten Public Offering
Sep 29 2025
Yahoo Finance
Science Applications International Analyst Changes Outlook; Top 3 Downgrades for Monday Revealed
Sep 08 2025
Benzinga
Artelo Biosciences Completes $3 Million Public Offering of Common Stock and Pre-Funded Warrants
Sep 05 2025
NASDAQ.COM
Artelo Biosciences Completes $3.0 Million Public Offering
Sep 05 2025
Newsfilter
Artelo Biosciences Sets $3 Million Price for Public Offering of Common Stock and Warrants
Sep 05 2025
NASDAQ.COM
Nasdaq Rises by More Than 100 Points; Science Applications Stock Declines Following Q2 Earnings Report
Sep 04 2025
Benzinga
Dow Jumps 200 Points as US Initial Jobless Claims Increase
Sep 04 2025
Benzinga
Artelo Biosciences' Medication Aids Cancer Patients in Weight Recovery, Pursuing Licensing Agreement
Sep 03 2025
Benzinga
Artelo Biosciences Confirms Promising Partnership Prospects for ART27.13 After Positive Interim Phase 2 CAReS Findings
Sep 03 2025
Newsfilter
Artelo Biosciences Reports Encouraging Interim Phase 2 Results for Cancer Anorexia-Cachexia Syndrome (CACS) Treatment
Sep 03 2025
Newsfilter
D. Boral Capital Reiterates Buy Rating for Artelo Biosciences with $18 Price Target Intact
Aug 26 2025
Benzinga
Show More News
